Company Evogene Ltd TEL AVIV STOCK EXCHANGE

Equities

IL0011050551

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

USD in Million	2022	Weight	2023	Weight	Delta
Agriculture 67.2 %	1	52.3 %	4	67.2 %	+332.76%
Industrial Applications 19.1 %	0	4.3 %	1	19.1 %	+1,393.06%
Human Health 8.6 %	1	30.6 %	0	8.6 %	-5.07%
Unallocated 5.1 %	0	12.8 %	0	5.1 %	+34.11%

USD in Million	2022	Weight	2023	Weight	Delta
United States 65.0 %	1	51.0 %	4	65.0 %	+329.15%
Others 19.0 %	0	4.0 %	1	19.0 %	+1,499.40%
Israel 16.0 %	1	45.0 %	1	16.0 %	+19.72%

Managers	Title	Age	Since
Ofer Haviv CEO	Chief Executive Officer	58	01-12-31
Yaron Eldad DFI	Director of Finance/CFO	57	22-03-31
Mark Kapel CTO	Chief Tech/Sci/R&D Officer	48	04-12-31
Eyal Ronen PRN	Corporate Officer/Principal	-	22-05-31
Sassi Masliah PRN	Corporate Officer/Principal	-	10-12-31
Liat Foigel Wejgman HRO	Human Resources Officer	-	14-12-31
Nir Arbel PRN	Corporate Officer/Principal	-	21-07-31
Yisrael Gewirtz AUD	Comptroller/Controller/Auditor	47	-

Members of the board	Title	Age	Since
Dan Falk BRD	Director/Board Member	79	21-11-16
Sarit Firon CHM	Chairman	58	16-08-10
Leon Recanati BRD	Director/Board Member	76	05-04-30
Ofer Haviv CEO	Chief Executive Officer	58	01-12-31
Oded Shoseyov BRD	Director/Board Member	67	18-10-31
Nir Nimrodi BRD	Director/Board Member	55	22-08-31
Adrian Percy BRD	Director/Board Member	59	19-02-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,584,888	49,746,029 ( 98.34 %)	0	98.34 %

Name	Equities	%	Valuation
SilverArc Capital Management LLC 6.133 %	3,100,000	6.133 %	2 M ILa
Leon Recanati 1.659 %	838,859	1.659 %	627 819 ILa
Walleye Capital LLC 0.6914 %	349,477	0.6914 %	261 556 ILa
KSM Mutual Funds Ltd. 0.5343 %	270,087	0.5343 %	202 139 ILa
Morgan Stanley Capital Services LLC 0.3728 %	188,446	0.3728 %	141 037 ILa
Migdal Mutual Funds Ltd. 0.2580 %	130,434	0.2580 %	97 619 ILa
P&S Vermögensberatungs AG Performance & Sicherheit 0.1978 %	100,000	0.1978 %	74 842 ILa
Excellence Nessuah Mutual Funds Management Ltd. 0.1457 %	73,648	0.1457 %	55 120 ILa
BNP Paribas Arbitrage SA 0.1383 %	69,900	0.1383 %	52 315 ILa
LPL Financial LLC 0.1322 %	66,835	0.1322 %	50 021 ILa

Evogene Ltd.

13 Gad Feinstein Street Park Rehovot

7638517, Rehovot

http://www.evogene.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+4.09%	43.43B
LONZA GROUP AG	+47.81%	41.69B
MODERNA, INC.	+9.45%	41.31B
CELLTRION, INC.	-10.92%	27.14B
ICON PUBLIC LIMITED COMPANY	+9.32%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-24.87%	18.47B
MEDPACE HOLDINGS, INC.	+29.70%	12.59B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	12.33B
UNITED THERAPEUTICS CORPORATION	+7.78%	11.03B

Other Biotechnology & Medical Research